Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioNeutra Global Corp V.BGA

Alternate Symbol(s):  BGACF

BioNeutra Global Corporation, through its subsidiaries, is involved in the research, development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on oligosaccharides. The Company’s lead product, VitaFiber IMO, is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. It produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops, including tapioca, field pea or corn into the functional health molecules of isomalto-oligosaccharide. VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. The Company’s customers include a mix of small and medium enterprises.


TSXV:BGA - Post by User

Post by MrWarrenBuffetton Dec 03, 2019 8:49am
257 Views
Post# 30416467

More losses!

More losses!

As expected, the company has suffered another multi-million dollar loss! No surprises here. 

Investors should be very suspicious of the reported slight increase in revenues. Things are not what it looks like. 

Have investors noticed that that accounts receivable sit at $3.6 million while accounts payable are at $14.8 million?

A red flag is the fact that the company blamed its financial woes on of a lack of supply. If that was the case then why are its inventory levels so high? You would think that a company that can't meet demand wouldn't have $14 million in inventories sitting around, right? You would think that if demand was so strong that the inventory levels would be at or close to zero, right? A lack of supply is not one of the company's problems. That would be too easy to fix if it was the case. 

Has anyone asked the company why it had supply issues? You know, the main reason was that the company has serious cash flow issues, couldn't pay its bills, and were cut off by their contract manufacturers. That’s what happens when you are a cash strapped middleman brokering a product that lost all of its value. IMO purchasers would be wise to buy their product directly from the manufacturers in China. Removing rhe middleman can allow food manufacturers to save time, money, and headaches. 

The company claims that does not anticipate further large write downs. When did the company register write downs in the first place? Don’t recall ever seeing that being reported before. There is doubt surrounding this statement considering that reported inventory levels have hardly changed.

And isn't it interesting how the MD&A completely ignores the very serious FDA issue?

The MD&A makes a lot of claims and promises but investors really need to be careful. The company just does not have the strategy, plan, vision, leadership, and people to generate prosperity for investors. Invest at your own risk.

<< Previous
Bullboard Posts
Next >>